 | • レポートコード：QFJ1-4329 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、ヒトDNAワクチンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子組換えタンパク質ワクチン、遺伝子ワクチン）、用途別市場規模（インフルエンザ、ヒトパピローマウイルス、HIV）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ヒトDNAワクチンの市場動向 ・企業の競争状況、市場シェア ・ヒトDNAワクチンの種類別市場規模と予測2016-2027（遺伝子組換えタンパク質ワクチン、遺伝子ワクチン） ・ヒトDNAワクチンの用途別市場規模と予測2016-2027（インフルエンザ、ヒトパピローマウイルス、HIV） ・ヒトDNAワクチンの北米市場規模2016-2027（アメリカ、カナダ） ・ヒトDNAワクチンの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ヒトDNAワクチンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ヒトDNAワクチンの中南米市場規模2016-2027（メキシコ、ブラジル） ・ヒトDNAワクチンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck、GSK、Sanofi、Zoties、Elanco、Boehringer-Ingelheim、Indian Immunologicals、Plumbline Life Sciences） ・結論 |
DNA vaccines have evolved greatly over the last 20 years since their invention, but have yet to become a competitive alternative to conventional protein or carbohydrate based human vaccines. Whilst safety concerns were an initial barrier, the Achilles heel of DNA vaccines remains their poor immunogenicity when compared to protein vaccines. A wide variety of strategies have been developed to optimize DNA vaccine immunogenicity, including codon optimization, genetic adjuvants, electroporation and sophisticated prime-boost regimens, with each of these methods having its advantages and limitations. Whilst each of these methods has contributed to incremental improvements in DNA vaccine efficacy, more is still needed if human DNA vaccines are to succeed commercially.
Market Analysis and Insights: Global Human DNA Vaccines Market
The global Human DNA Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Human DNA Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Human DNA Vaccines market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Human DNA Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Human DNA Vaccines market.
Global Human DNA Vaccines Scope and Market Size
Human DNA Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human DNA Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Recombinant Protein Vaccine
Gene-Based Vaccine
Segment by Application
Influenza
Human Papillomavirus
HIV
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human DNA Vaccines Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Recombinant Protein Vaccine
1.2.3 Gene-Based Vaccine
1.3 Market by Application
1.3.1 Global Human DNA Vaccines Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Influenza
1.3.3 Human Papillomavirus
1.3.4 HIV
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Human DNA Vaccines Market Perspective (2016-2027)
2.2 Human DNA Vaccines Growth Trends by Regions
2.2.1 Human DNA Vaccines Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Human DNA Vaccines Historic Market Share by Regions (2016-2021)
2.2.3 Human DNA Vaccines Forecasted Market Size by Regions (2022-2027)
2.3 Human DNA Vaccines Industry Dynamic
2.3.1 Human DNA Vaccines Market Trends
2.3.2 Human DNA Vaccines Market Drivers
2.3.3 Human DNA Vaccines Market Challenges
2.3.4 Human DNA Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human DNA Vaccines Players by Revenue
3.1.1 Global Top Human DNA Vaccines Players by Revenue (2016-2021)
3.1.2 Global Human DNA Vaccines Revenue Market Share by Players (2016-2021)
3.2 Global Human DNA Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Human DNA Vaccines Revenue
3.4 Global Human DNA Vaccines Market Concentration Ratio
3.4.1 Global Human DNA Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human DNA Vaccines Revenue in 2020
3.5 Human DNA Vaccines Key Players Head office and Area Served
3.6 Key Players Human DNA Vaccines Product Solution and Service
3.7 Date of Enter into Human DNA Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human DNA Vaccines Breakdown Data by Type
4.1 Global Human DNA Vaccines Historic Market Size by Type (2016-2021)
4.2 Global Human DNA Vaccines Forecasted Market Size by Type (2022-2027)
5 Human DNA Vaccines Breakdown Data by Application
5.1 Global Human DNA Vaccines Historic Market Size by Application (2016-2021)
5.2 Global Human DNA Vaccines Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Human DNA Vaccines Market Size (2016-2027)
6.2 North America Human DNA Vaccines Market Size by Type
6.2.1 North America Human DNA Vaccines Market Size by Type (2016-2021)
6.2.2 North America Human DNA Vaccines Market Size by Type (2022-2027)
6.2.3 North America Human DNA Vaccines Market Size by Type (2016-2027)
6.3 North America Human DNA Vaccines Market Size by Application
6.3.1 North America Human DNA Vaccines Market Size by Application (2016-2021)
6.3.2 North America Human DNA Vaccines Market Size by Application (2022-2027)
6.3.3 North America Human DNA Vaccines Market Size by Application (2016-2027)
6.4 North America Human DNA Vaccines Market Size by Country
6.4.1 North America Human DNA Vaccines Market Size by Country (2016-2021)
6.4.2 North America Human DNA Vaccines Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Human DNA Vaccines Market Size (2016-2027)
7.2 Europe Human DNA Vaccines Market Size by Type
7.2.1 Europe Human DNA Vaccines Market Size by Type (2016-2021)
7.2.2 Europe Human DNA Vaccines Market Size by Type (2022-2027)
7.2.3 Europe Human DNA Vaccines Market Size by Type (2016-2027)
7.3 Europe Human DNA Vaccines Market Size by Application
7.3.1 Europe Human DNA Vaccines Market Size by Application (2016-2021)
7.3.2 Europe Human DNA Vaccines Market Size by Application (2022-2027)
7.3.3 Europe Human DNA Vaccines Market Size by Application (2016-2027)
7.4 Europe Human DNA Vaccines Market Size by Country
7.4.1 Europe Human DNA Vaccines Market Size by Country (2016-2021)
7.4.2 Europe Human DNA Vaccines Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Human DNA Vaccines Market Size (2016-2027)
8.2 Asia-Pacific Human DNA Vaccines Market Size by Type
8.2.1 Asia-Pacific Human DNA Vaccines Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Human DNA Vaccines Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Human DNA Vaccines Market Size by Type (2016-2027)
8.3 Asia-Pacific Human DNA Vaccines Market Size by Application
8.3.1 Asia-Pacific Human DNA Vaccines Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Human DNA Vaccines Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Human DNA Vaccines Market Size by Application (2016-2027)
8.4 Asia-Pacific Human DNA Vaccines Market Size by Region
8.4.1 Asia-Pacific Human DNA Vaccines Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Human DNA Vaccines Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Human DNA Vaccines Market Size (2016-2027)
9.2 Latin America Human DNA Vaccines Market Size by Type
9.2.1 Latin America Human DNA Vaccines Market Size by Type (2016-2021)
9.2.2 Latin America Human DNA Vaccines Market Size by Type (2022-2027)
9.2.3 Latin America Human DNA Vaccines Market Size by Type (2016-2027)
9.3 Latin America Human DNA Vaccines Market Size by Application
9.3.1 Latin America Human DNA Vaccines Market Size by Application (2016-2021)
9.3.2 Latin America Human DNA Vaccines Market Size by Application (2022-2027)
9.3.3 Latin America Human DNA Vaccines Market Size by Application (2016-2027)
9.4 Latin America Human DNA Vaccines Market Size by Country
9.4.1 Latin America Human DNA Vaccines Market Size by Country (2016-2021)
9.4.2 Latin America Human DNA Vaccines Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human DNA Vaccines Market Size (2016-2027)
10.2 Middle East & Africa Human DNA Vaccines Market Size by Type
10.2.1 Middle East & Africa Human DNA Vaccines Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Human DNA Vaccines Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Human DNA Vaccines Market Size by Type (2016-2027)
10.3 Middle East & Africa Human DNA Vaccines Market Size by Application
10.3.1 Middle East & Africa Human DNA Vaccines Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Human DNA Vaccines Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Human DNA Vaccines Market Size by Application (2016-2027)
10.4 Middle East & Africa Human DNA Vaccines Market Size by Country
10.4.1 Middle East & Africa Human DNA Vaccines Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Human DNA Vaccines Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Human DNA Vaccines Introduction
11.1.4 Merck Revenue in Human DNA Vaccines Business (2016-2021)
11.1.5 Merck Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Human DNA Vaccines Introduction
11.2.4 GSK Revenue in Human DNA Vaccines Business (2016-2021)
11.2.5 GSK Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Human DNA Vaccines Introduction
11.3.4 Sanofi Revenue in Human DNA Vaccines Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Zoties
11.4.1 Zoties Company Details
11.4.2 Zoties Business Overview
11.4.3 Zoties Human DNA Vaccines Introduction
11.4.4 Zoties Revenue in Human DNA Vaccines Business (2016-2021)
11.4.5 Zoties Recent Development
11.5 Elanco
11.5.1 Elanco Company Details
11.5.2 Elanco Business Overview
11.5.3 Elanco Human DNA Vaccines Introduction
11.5.4 Elanco Revenue in Human DNA Vaccines Business (2016-2021)
11.5.5 Elanco Recent Development
11.6 Boehringer-Ingelheim
11.6.1 Boehringer-Ingelheim Company Details
11.6.2 Boehringer-Ingelheim Business Overview
11.6.3 Boehringer-Ingelheim Human DNA Vaccines Introduction
11.6.4 Boehringer-Ingelheim Revenue in Human DNA Vaccines Business (2016-2021)
11.6.5 Boehringer-Ingelheim Recent Development
11.7 Indian Immunologicals
11.7.1 Indian Immunologicals Company Details
11.7.2 Indian Immunologicals Business Overview
11.7.3 Indian Immunologicals Human DNA Vaccines Introduction
11.7.4 Indian Immunologicals Revenue in Human DNA Vaccines Business (2016-2021)
11.7.5 Indian Immunologicals Recent Development
11.8 Plumbline Life Sciences
11.8.1 Plumbline Life Sciences Company Details
11.8.2 Plumbline Life Sciences Business Overview
11.8.3 Plumbline Life Sciences Human DNA Vaccines Introduction
11.8.4 Plumbline Life Sciences Revenue in Human DNA Vaccines Business (2016-2021)
11.8.5 Plumbline Life Sciences Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Human DNA Vaccines Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Recombinant Protein Vaccine
Table 3. Key Players of Gene-Based Vaccine
Table 4. Global Human DNA Vaccines Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Human DNA Vaccines Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Human DNA Vaccines Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Human DNA Vaccines Market Share by Regions (2016-2021)
Table 8. Global Human DNA Vaccines Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Human DNA Vaccines Market Share by Regions (2022-2027)
Table 10. Human DNA Vaccines Market Trends
Table 11. Human DNA Vaccines Market Drivers
Table 12. Human DNA Vaccines Market Challenges
Table 13. Human DNA Vaccines Market Restraints
Table 14. Global Human DNA Vaccines Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Human DNA Vaccines Market Share by Players (2016-2021)
Table 16. Global Top Human DNA Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human DNA Vaccines as of 2020)
Table 17. Ranking of Global Top Human DNA Vaccines Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Human DNA Vaccines Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Human DNA Vaccines Product Solution and Service
Table 21. Date of Enter into Human DNA Vaccines Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human DNA Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Human DNA Vaccines Revenue Market Share by Type (2016-2021)
Table 25. Global Human DNA Vaccines Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Human DNA Vaccines Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Human DNA Vaccines Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Human DNA Vaccines Revenue Market Share by Application (2016-2021)
Table 29. Global Human DNA Vaccines Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Human DNA Vaccines Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Human DNA Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Human DNA Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Human DNA Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Human DNA Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Human DNA Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Human DNA Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Human DNA Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Human DNA Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Human DNA Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Human DNA Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Human DNA Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Human DNA Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Human DNA Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Human DNA Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Human DNA Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Human DNA Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Human DNA Vaccines Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Human DNA Vaccines Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Human DNA Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Human DNA Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Human DNA Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Human DNA Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Human DNA Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Human DNA Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Human DNA Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Human DNA Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Human DNA Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Human DNA Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Human DNA Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Human DNA Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 61. Merck Company Details
Table 62. Merck Business Overview
Table 63. Merck Human DNA Vaccines Product
Table 64. Merck Revenue in Human DNA Vaccines Business (2016-2021) & (US$ Million)
Table 65. Merck Recent Development
Table 66. GSK Company Details
Table 67. GSK Business Overview
Table 68. GSK Human DNA Vaccines Product
Table 69. GSK Revenue in Human DNA Vaccines Business (2016-2021) & (US$ Million)
Table 70. GSK Recent Development
Table 71. Sanofi Company Details
Table 72. Sanofi Business Overview
Table 73. Sanofi Human DNA Vaccines Product
Table 74. Sanofi Revenue in Human DNA Vaccines Business (2016-2021) & (US$ Million)
Table 75. Sanofi Recent Development
Table 76. Zoties Company Details
Table 77. Zoties Business Overview
Table 78. Zoties Human DNA Vaccines Product
Table 79. Zoties Revenue in Human DNA Vaccines Business (2016-2021) & (US$ Million)
Table 80. Zoties Recent Development
Table 81. Elanco Company Details
Table 82. Elanco Business Overview
Table 83. Elanco Human DNA Vaccines Product
Table 84. Elanco Revenue in Human DNA Vaccines Business (2016-2021) & (US$ Million)
Table 85. Elanco Recent Development
Table 86. Boehringer-Ingelheim Company Details
Table 87. Boehringer-Ingelheim Business Overview
Table 88. Boehringer-Ingelheim Human DNA Vaccines Product
Table 89. Boehringer-Ingelheim Revenue in Human DNA Vaccines Business (2016-2021) & (US$ Million)
Table 90. Boehringer-Ingelheim Recent Development
Table 91. Indian Immunologicals Company Details
Table 92. Indian Immunologicals Business Overview
Table 93. Indian Immunologicals Human DNA Vaccines Product
Table 94. Indian Immunologicals Revenue in Human DNA Vaccines Business (2016-2021) & (US$ Million)
Table 95. Indian Immunologicals Recent Development
Table 96. Plumbline Life Sciences Company Details
Table 97. Plumbline Life Sciences Business Overview
Table 98. Plumbline Life Sciences Revenue in Human DNA Vaccines Business (2016-2021) & (US$ Million)
Table 99. Plumbline Life Sciences Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human DNA Vaccines Market Share by Type: 2020 VS 2027
Figure 2. Recombinant Protein Vaccine Features
Figure 3. Gene-Based Vaccine Features
Figure 4. Global Human DNA Vaccines Market Share by Application: 2020 VS 2027
Figure 5. Influenza Case Studies
Figure 6. Human Papillomavirus Case Studies
Figure 7. HIV Case Studies
Figure 8. Human DNA Vaccines Report Years Considered
Figure 9. Global Human DNA Vaccines Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Human DNA Vaccines Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Human DNA Vaccines Market Share by Regions: 2020 VS 2027
Figure 12. Global Human DNA Vaccines Market Share by Regions (2022-2027)
Figure 13. Global Human DNA Vaccines Market Share by Players in 2020
Figure 14. Global Top Human DNA Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human DNA Vaccines as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Human DNA Vaccines Revenue in 2020
Figure 16. Global Human DNA Vaccines Revenue Market Share by Type (2016-2021)
Figure 17. Global Human DNA Vaccines Revenue Market Share by Type (2022-2027)
Figure 18. North America Human DNA Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Human DNA Vaccines Market Share by Type (2016-2027)
Figure 20. North America Human DNA Vaccines Market Share by Application (2016-2027)
Figure 21. North America Human DNA Vaccines Market Share by Country (2016-2027)
Figure 22. United States Human DNA Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Human DNA Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Human DNA Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Human DNA Vaccines Market Share by Type (2016-2027)
Figure 26. Europe Human DNA Vaccines Market Share by Application (2016-2027)
Figure 27. Europe Human DNA Vaccines Market Share by Country (2016-2027)
Figure 28. Germany Human DNA Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Human DNA Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Human DNA Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Human DNA Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Human DNA Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Human DNA Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Human DNA Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Human DNA Vaccines Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Human DNA Vaccines Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Human DNA Vaccines Market Share by Region (2016-2027)
Figure 38. China Human DNA Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Human DNA Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Human DNA Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Human DNA Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Human DNA Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Human DNA Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Human DNA Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Human DNA Vaccines Market Share by Type (2016-2027)
Figure 46. Latin America Human DNA Vaccines Market Share by Application (2016-2027)
Figure 47. Latin America Human DNA Vaccines Market Share by Country (2016-2027)
Figure 48. Mexico Human DNA Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Human DNA Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Human DNA Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Human DNA Vaccines Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Human DNA Vaccines Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Human DNA Vaccines Market Share by Country (2016-2027)
Figure 54. Turkey Human DNA Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Human DNA Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Human DNA Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Merck Revenue Growth Rate in Human DNA Vaccines Business (2016-2021)
Figure 58. GSK Revenue Growth Rate in Human DNA Vaccines Business (2016-2021)
Figure 59. Sanofi Revenue Growth Rate in Human DNA Vaccines Business (2016-2021)
Figure 60. Zoties Revenue Growth Rate in Human DNA Vaccines Business (2016-2021)
Figure 61. Elanco Revenue Growth Rate in Human DNA Vaccines Business (2016-2021)
Figure 62. Boehringer-Ingelheim Revenue Growth Rate in Human DNA Vaccines Business (2016-2021)
Figure 63. Indian Immunologicals Revenue Growth Rate in Human DNA Vaccines Business (2016-2021)
Figure 64. Plumbline Life Sciences Revenue Growth Rate in Human DNA Vaccines Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
ヒトDNAワクチンのグローバル市場：規模・現状・予測2019-2025 DNA vaccines have evolved greatly over the last 20 years since their invention, but have yet to become a competitive alternative to conventional protein or carbohydrate based human vaccines. Whilst safety concerns were an initial barrier, the Achilles heel of DNA vaccines remains their poor immunoge…- ヒトDNAワクチンのグローバル市場：規模・現状・予測2019-2025 DNA vaccines have evolved greatly over the last 20 years since their invention, but have yet to become a competitive alternative to conventional protein or carbohydrate based human vaccines. Whilst safety concerns were an initial barrier, the Achilles heel of DNA vaccines remains their poor immunoge…
- ヒトDNAワクチンのグローバル市場：規模・現状・予測2019-2025 DNA vaccines have evolved greatly over the last 20 years since their invention, but have yet to become a competitive alternative to conventional protein or carbohydrate based human vaccines. Whilst safety concerns were an initial barrier, the Achilles heel of DNA vaccines remains their poor immunoge…
- 人用ワクチンのグローバル市場2021 A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. China …
- 世界のヒト狂犬病治療市場規模・現状・予測（2021年-2027年） Rabies is a fatal neurological disease, usually spread to humans through the bite of a rabid animal, and it is a persistent global problem. Market Analysis and Insights: Global Human Rabies Treatment Market The global Human Rabies Treatment market size is projected to reach US$ XX million by 2027, f…